ABVD or BEACOPP(baseline) along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Etude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial

C Ferme; J Thomas; P Brice; O Casasnovas; A Vranovsky; S Bologna; Elly Lugtenburg; R Bouabdallah; P Carde; C Sebban; H Eghbali; G Salles; GW van Imhoff; A Thyss; EM Noordijk; O Reman; MLM Lybeert; M Janvier; M Spina; B Audhuy; JMM Raemaekers; R Delarue; B Anglaret; O de Weerdt; Z Marjanovic; R Tersteeg; D de Jong; J Briere; M Henry-Amar

doi:10.1016/j.ejca.2017.05.005

ABVD or BEACOPP(baseline) along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Etude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial

C Ferme, J Thomas, P Brice, O Casasnovas, A Vranovsky, S Bologna, Elly Lugtenburg, R Bouabdallah, P Carde, C Sebban, H Eghbali, G Salles, GW van Imhoff, A Thyss, EM Noordijk, O Reman, MLM Lybeert, M Janvier, M Spina, B AudhuyJMM Raemaekers, R Delarue, B Anglaret, O de Weerdt, Z Marjanovic, R Tersteeg, D de Jong, J Briere, M Henry-Amar

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

26 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	45-55
Number of pages	11
Journal	European Journal of Cancer
Volume	81
DOIs	https://doi.org/10.1016/j.ejca.2017.05.005
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2017.05.005

http://hdl.handle.net/1765/100405

Cite this

Ferme, C., Thomas, J., Brice, P., Casasnovas, O., Vranovsky, A., Bologna, S., Lugtenburg, E., Bouabdallah, R., Carde, P., Sebban, C., Eghbali, H., Salles, G., van Imhoff, GW., Thyss, A., Noordijk, EM., Reman, O., Lybeert, MLM., Janvier, M., Spina, M., ... Henry-Amar, M. (2017). ABVD or BEACOPP(baseline) along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Etude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial. European Journal of Cancer, 81, 45-55. https://doi.org/10.1016/j.ejca.2017.05.005

Ferme, C ; Thomas, J ; Brice, P et al. / ABVD or BEACOPP(baseline) along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Etude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial. In: European Journal of Cancer. 2017 ; Vol. 81. pp. 45-55.

@article{a2e97e6aa07243d5bedecf5b9f13dd66,

title = "ABVD or BEACOPP(baseline) along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Etude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial",

author = "C Ferme and J Thomas and P Brice and O Casasnovas and A Vranovsky and S Bologna and Elly Lugtenburg and R Bouabdallah and P Carde and C Sebban and H Eghbali and G Salles and {van Imhoff}, GW and A Thyss and EM Noordijk and O Reman and MLM Lybeert and M Janvier and M Spina and B Audhuy and JMM Raemaekers and R Delarue and B Anglaret and {de Weerdt}, O and Z Marjanovic and R Tersteeg and {de Jong}, D and J Briere and M Henry-Amar",

year = "2017",

doi = "10.1016/j.ejca.2017.05.005",

language = "Undefined/Unknown",

volume = "81",

pages = "45--55",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Ferme, C, Thomas, J, Brice, P, Casasnovas, O, Vranovsky, A, Bologna, S, Lugtenburg, E, Bouabdallah, R, Carde, P, Sebban, C, Eghbali, H, Salles, G, van Imhoff, GW, Thyss, A, Noordijk, EM, Reman, O, Lybeert, MLM, Janvier, M, Spina, M, Audhuy, B, Raemaekers, JMM, Delarue, R, Anglaret, B, de Weerdt, O, Marjanovic, Z, Tersteeg, R, de Jong, D, Briere, J & Henry-Amar, M 2017, 'ABVD or BEACOPP(baseline) along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Etude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial', European Journal of Cancer, vol. 81, pp. 45-55. https://doi.org/10.1016/j.ejca.2017.05.005

ABVD or BEACOPP(baseline) along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Etude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial. / Ferme, C; Thomas, J; Brice, P et al.
In: European Journal of Cancer, Vol. 81, 2017, p. 45-55.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - ABVD or BEACOPP(baseline) along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Etude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial

AU - Ferme, C

AU - Thomas, J

AU - Brice, P

AU - Casasnovas, O

AU - Vranovsky, A

AU - Bologna, S

AU - Lugtenburg, Elly

AU - Bouabdallah, R

AU - Carde, P

AU - Sebban, C

AU - Eghbali, H

AU - Salles, G

AU - van Imhoff, GW

AU - Thyss, A

AU - Noordijk, EM

AU - Reman, O

AU - Lybeert, MLM

AU - Janvier, M

AU - Spina, M

AU - Audhuy, B

AU - Raemaekers, JMM

AU - Delarue, R

AU - Anglaret, B

AU - de Weerdt, O

AU - Marjanovic, Z

AU - Tersteeg, R

AU - de Jong, D

AU - Briere, J

AU - Henry-Amar, M

PY - 2017

Y1 - 2017

U2 - 10.1016/j.ejca.2017.05.005

DO - 10.1016/j.ejca.2017.05.005

M3 - Article

SN - 0959-8049

VL - 81

SP - 45

EP - 55

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Ferme C, Thomas J, Brice P, Casasnovas O, Vranovsky A, Bologna S et al. ABVD or BEACOPP(baseline) along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Etude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial. European Journal of Cancer. 2017;81:45-55. doi: 10.1016/j.ejca.2017.05.005